Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
AI-Driven Management of Type 2 Diabetes in China: Opportunities and Challenges
7
Zitationen
2
Autoren
2025
Jahr
Abstract
With the aging of China's population and lifestyle changes, the number of patients with type 2 diabetes (T2D) has surged, posing a significant challenge to the public health system. This study explores the application and effectiveness of artificial intelligence (AI) technology in T2D management from a Chinese perspective. AI demonstrates substantial potential in personalized treatment planning, real-time monitoring and early warning, telemedicine, and health management. It not only enhances the precision and convenience of treatment but also aids in preventing and managing complications. Despite challenges in data privacy, technology popularization, standardization, and regulation, AI technology's continuous maturation and expanded application suggest its increasingly pivotal role in T2D management. In the future, through interdepartmental collaboration, policy support, and cultural adaptation, AI is poised to bring revolutionary changes to diabetes management in China and globally.
Ähnliche Arbeiten
Biostatistical Analysis
1996 · 35.445 Zit.
UCI Machine Learning Repository
2007 · 24.290 Zit.
An introduction to ROC analysis
2005 · 20.619 Zit.
The use of the area under the ROC curve in the evaluation of machine learning algorithms
1997 · 7.106 Zit.
A method of comparing the areas under receiver operating characteristic curves derived from the same cases.
1983 · 7.062 Zit.